98 related articles for article (PubMed ID: 15013447)
1. Suppression of Epstein-Barr virus-encoded latent membrane protein-1 by RNA interference inhibits the metastatic potential of nasopharyngeal carcinoma cells.
Li XP; Li G; Peng Y; Kung HF; Lin MC
Biochem Biophys Res Commun; 2004 Feb; 315(1):212-8. PubMed ID: 15013447
[TBL] [Abstract][Full Text] [Related]
2. Recombinant adeno-associated virus mediated RNA interference inhibits metastasis of nasopharyngeal cancer cells in vivo and in vitro by suppression of Epstein-Barr virus encoded LMP-1.
Li X; Liu X; Li CY; Ding Y; Chau D; Li G; Kung HF; Lin MC; Peng Y
Int J Oncol; 2006 Sep; 29(3):595-603. PubMed ID: 16865275
[TBL] [Abstract][Full Text] [Related]
3. [Inhibition of EBV-encoded LMP-1 by DNA-based RNA interference affects metastatic ability of nasopharyngeal carcinoma cells].
Li G; Li XP; Liu X; Peng Y; Lin MC
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):724-7. PubMed ID: 17366780
[TBL] [Abstract][Full Text] [Related]
4. [Effect of rAAV-mediated RNA interference against EB virus-encoded latent membrane protein 1 on nasopharyngeal carcinoma cell proliferation and metastasis in nude mice].
Liu X; Liu X; Li G; Zhang B; Wang L; Li XH; Li XP
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Apr; 29(4):611-4. PubMed ID: 19403376
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
[TBL] [Abstract][Full Text] [Related]
6. Effect of inhibition of EBV-encoded latent membrane protein-1 by small interfering RNA on EBV-positive nasopharyngeal carcinoma cell growth.
Li G; Li XP; Peng Y; Liu X; Li XH
Di Yi Jun Yi Da Xue Xue Bao; 2004 Mar; 24(3):241-6. PubMed ID: 15041532
[TBL] [Abstract][Full Text] [Related]
7. [Effects of Epstein-Barr virus latent membrane protein 1(EBV-LMP1) on related factors of metastasis of nasopharyngeal carcinoma cell line CNE1].
Gou XM; Chen Y; Chen XY; Arrand JR
Ai Zheng; 2003 May; 22(5):481-5. PubMed ID: 12753707
[TBL] [Abstract][Full Text] [Related]
8. [Influence of suppression of Epstein-Barr Virus-encoded latent membrane protein 1 by rAAV vector mediated RNA interference on metastatic ability of nasopharyngeal cancer cells in vivo].
Liu X; Li G; Zhang B; Wang L; Li XH; Li XP
Zhonghua Zhong Liu Za Zhi; 2009 May; 31(5):324-9. PubMed ID: 19799078
[TBL] [Abstract][Full Text] [Related]
9. Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion.
Ho CH; Chen CL; Li WY; Chen CJ
Carcinogenesis; 2009 Aug; 30(8):1443-51. PubMed ID: 19483191
[TBL] [Abstract][Full Text] [Related]
10. [Effects of Epstein-Barr virus latent membrane protein 1 on metastasis of human nasopharyngeal carcinoma cell lines].
Ou XB; Chen XY; Wu MH; Luo WR
Ai Zheng; 2008 Aug; 27(8):803-8. PubMed ID: 18710612
[TBL] [Abstract][Full Text] [Related]
11. Molecular diagnosis of nasopharyngeal carcinoma using detection of Epstein-Barr virus latent membrane protein-1 gene in cervical metastatic lymph nodes.
Khademi B; Mahmoudi J; Monabati A; Maghsoudi B; Ashraf MJ; Mohammadianpanah M; Tabibi N; Valibeigi B; Abedi E
Am J Otolaryngol; 2009; 30(2):95-100. PubMed ID: 19239950
[TBL] [Abstract][Full Text] [Related]
12. Expression of syndecan-1 (CD138) in nasopharyngeal carcinoma is correlated with advanced stage and poor prognosis.
Chen CL; Ou DL
Hum Pathol; 2006 Oct; 37(10):1279-85. PubMed ID: 16949936
[TBL] [Abstract][Full Text] [Related]
13. Induction of interleukin-8 by Epstein-Barr virus latent membrane protein-1 and its correlation to angiogenesis in nasopharyngeal carcinoma.
Yoshizaki T; Horikawa T; Qing-Chun R; Wakisaka N; Takeshita H; Sheen TS; Lee SY; Sato H; Furukawa M
Clin Cancer Res; 2001 Jul; 7(7):1946-51. PubMed ID: 11448908
[TBL] [Abstract][Full Text] [Related]
14. Induction of matrix metalloproteinases by Epstein-Barr virus latent membrane protein 1 isolated from nasopharyngeal carcinoma.
Lee DC; Chua DT; Wei WI; Sham JS; Lau AS
Biomed Pharmacother; 2007 Oct; 61(9):520-6. PubMed ID: 17913445
[TBL] [Abstract][Full Text] [Related]
15. [Inhibiting target gene expression and controlling growth of Epstein-Barr virus transformed cells by antisense RNA transcripts].
Chen JJ; Raab-Traub N; Yao QY; Zhang F; Huang ML; Kuang ZJ; Zhang XS; Ye YL; Gu L
Ai Zheng; 2002 Jan; 21(1):16-20. PubMed ID: 12500390
[TBL] [Abstract][Full Text] [Related]
16. Induction of c-Met proto-oncogene by Epstein-Barr virus latent membrane protein-1 and the correlation with cervical lymph node metastasis of nasopharyngeal carcinoma.
Horikawa T; Sheen TS; Takeshita H; Sato H; Furukawa M; Yoshizaki T
Am J Pathol; 2001 Jul; 159(1):27-33. PubMed ID: 11438450
[TBL] [Abstract][Full Text] [Related]
17. Expression and clinical significance of latent membrane protein-1, matrix metalloproteinase-1 and Ets-1 transcription factor in tunisian nasopharyngeal carcinoma patients.
Ben Nasr H; Chahed K; Remadi S; Zakhama A; Chouchane L
Arch Med Res; 2009 Apr; 40(3):196-203. PubMed ID: 19427971
[TBL] [Abstract][Full Text] [Related]
18. [Effective inhibition of EB virus-encoded latent membrane protein-1 by siRNA in EB virus (+) nasopharyngeal carcinoma cell].
Li G; Li XP; Peng Y; Liu X; Li XH
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2005 Jun; 40(6):406-10. PubMed ID: 16145771
[TBL] [Abstract][Full Text] [Related]
19. Cooperative interactions among p53, bcl-2 and Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma cells.
Sheu LF; Chen A; Lee HS; Hsu HY; Yu DS
Pathol Int; 2004 Jul; 54(7):475-85. PubMed ID: 15189500
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of recurrent nasopharyngeal carcinoma and skull base osteoradionecrosis by Epstein-Barr virus-derived latent membrane protein-1 gene.
Hao SP; Tsang NM; Chang KP
Laryngoscope; 2001 Apr; 111(4 Pt 1):650-2. PubMed ID: 11359135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
